Quick Answer
ORAGENICS INC reported Total Revenue of $37.7 thousand for fiscal year 2023.
ORAGENICS INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | $37.7K -71.4% |
$131.5K +51.2% |
$87.0K | — |
| Revenue (ASC 606) | — | — | $37.7K -71.4% |
$131.5K +51.2% |
$87.0K | — |
| Net Income | -$9.84M +6.9% |
-$10.57M +48.8% |
-$20.66M -44.6% |
-$14.29M +9.1% |
-$15.71M +40.6% |
-$26.43M -69.8% |
| Diluted EPS | -$4.56 +90.5% |
-$47.88 -421.6% |
-$9.18 -29.1% |
-$7.11 | — | — |
| Total Assets | $10.07M +583.7% |
$1.47M -70.4% |
$4.97M -66.3% |
$14.76M -47.7% |
$28.23M +51.1% |
$18.68M -5.4% |
| Cash and Equivalents | $4.40M +408.7% |
$864.8K -75.2% |
$3.48M -69.5% |
$11.43M -58.1% |
$27.27M +54.6% |
$17.64M -3.4% |
| Stockholders Equity | $8.28M +4008.4% |
-$211.9K -106.7% |
$3.17M -75.6% |
$13.01M -50.9% |
$26.49M +57.2% |
$16.84M -2.2% |
| R&D Expense | $2.39M -41.8% |
$4.11M -73.4% |
$15.49M +53.8% |
$10.07M -4.9% |
$10.59M -52.1% |
$22.11M +82.4% |
| Operating Income | -$9.36M +11.3% |
-$10.56M +49.5% |
-$20.90M -45.0% |
-$14.42M +8.6% |
-$15.77M +40.8% |
-$26.64M -67.8% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 4.27M +919.5% |
419,003 -79.0% |
2.00M -1.2% |
2.02M +1.1% |
2.00M -97.8% |
91.77M +99.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2023 | $7.5K | -91.3% | -43.3% |
| Revenue (ASC 606) | September 30, 2023 | $7.5K | -91.3% | -43.3% |
| Net Income | September 30, 2025 | -$3.07M | -24.5% | -35.0% |
| Diluted EPS | September 30, 2025 | -$1.96 | +82.7% | +36.8% |
| Total Assets | September 30, 2025 | $12.71M | +144.1% | +493.8% |
| Cash and Equivalents | September 30, 2025 | $11.40M | +262.7% | +477.8% |
| Stockholders Equity | September 30, 2025 | $9.83M | +219.5% | +562.1% |
| R&D Expense | September 30, 2025 | $930.9K | +5.9% | +107.0% |
| Operating Income | September 30, 2025 | -$3.12M | -28.2% | -82.2% |
| Gross Profit | September 30, 2016 | $0.00 | — | — |
| Shares Outstanding | September 30, 2025 | 4.13M | -56.0% | +401.5% |
- ORAGENICS INC reported Total Revenue of $37.7 thousand for fiscal year 2023.
- ORAGENICS INC showed a decrease of -71.4% in Total Revenue compared to the prior fiscal year.
- ORAGENICS INC reported Revenue (ASC 606) of $37.7 thousand for fiscal year 2023.
- ORAGENICS INC showed a decrease of -71.4% in Revenue (ASC 606) compared to the prior fiscal year.
- ORAGENICS INC reported Net Income of -$9.84 million for fiscal year 2025.
- ORAGENICS INC showed an increase of +6.9% in Net Income compared to the prior fiscal year.
- ORAGENICS INC reported Diluted EPS of $4.56 per share (loss) for fiscal year 2025.
- ORAGENICS INC showed an increase of +90.5% in Diluted EPS compared to the prior fiscal year.
- ORAGENICS INC reported Total Assets of $10.07 million for fiscal year 2025.
- ORAGENICS INC showed an increase of +583.7% in Total Assets compared to the prior fiscal year.
- ORAGENICS INC reported Cash and Equivalents of $4.40 million for fiscal year 2025.
- ORAGENICS INC showed an increase of +408.7% in Cash and Equivalents compared to the prior fiscal year.
- ORAGENICS INC reported Stockholders Equity of $8.28 million for fiscal year 2025.
- ORAGENICS INC showed an increase of +4008.4% in Stockholders Equity compared to the prior fiscal year.
- ORAGENICS INC reported R&D Expense of $2.39 million for fiscal year 2025.
- ORAGENICS INC showed a decrease of -41.8% in R&D Expense compared to the prior fiscal year.
- ORAGENICS INC reported Operating Income of -$9.36 million for fiscal year 2025.
- ORAGENICS INC showed an increase of +11.3% in Operating Income compared to the prior fiscal year.
- ORAGENICS INC reported Gross Profit of $0.00 for fiscal year 2017.
- ORAGENICS INC reported Shares Outstanding of 4.27 million shares for fiscal year 2025.
- ORAGENICS INC showed an increase of +919.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: